AURO LABORATORIES LTD. Share Price

AURO LABORATORIES LTD. Share Price

BSE: 530233
|
Pharmaceuticals
|
S Cap
₹ 247.75
+₹7.65 (3.19%)
1D
Last updated 14 Aug, 2026, 10:37 IST

AURO LABORATORIES LTD. Share Price Today

As of 14 Aug 2026, AURO LABORATORIES LTD. share price is ₹247.75. The stock opened at ₹259.95, compared to its previous close of ₹240.10. During today's trading session, AURO LABORATORIES LTD. share price moved in the range of ₹247.75 to ₹259.95, with an average price of ₹253.85 for the day. Looking at its last 52-week, the stock has touched a low of ₹159.00 and a high of ₹317.00.

₹247.75
3.19% up today
₹259.95
1D LOW
1D HIGH

AURO LABORATORIES LTD. Returns Calculator

Circuit
L
H
₹192.10
₹288.10
52-week
L
H
₹159.00
₹317.00

About AURO LABORATORIES LTD.

AURO LABORATORIES LTD. Share Price
ISIN
INE292C01011
Sector Market Cap
₹ 149.64 Cr

Auro Laboratories Limited is an India-based company, which is engaged in the manufacturing activities of active pharmaceutical ingredients (APIs). The Company is specializing in producing anti-diabetics like Metformin HCL, which is used in the treatment of type 2 diabetes. It also undertakes toll/custom manufacturing for API's and intermediates on a contract basis. The Company's API products include antihistamine, muscle relaxant, diuretic, iron deficiency, anti-diabetics, anti-fungal, anti-ulcer, iodine supplement, anti-malaria, analgesics, antacids, anti-inflammatory, specialty chemicals and others. Its intermediate products include glibenclamde sulphonamide, cis-bramo benzoate, cls-tosylate, 2-ethoxy benzoic acid, 2-ethoxy benzoic acid, among others. It offers its manufacturing and technical services, such as process scale up, process optimization, custom synthesis and custom manufacturing. It exports to Southeast Asia, Middle East and several European countries.

AURO LABORATORIES LTD. Financial Highlights

  • Revenue: AURO LABORATORIES LTD. reported revenue of ₹32.75 crore in FY26 vs ₹20.06 crore in FY25. It showed an increase of 63.26% on a yearly basis.
  • Operating Profit: AURO LABORATORIES LTD. reported an operating profit of ₹4.81 crore in FY26 vs ₹1.88 crore in FY25. It showed an increase of 155.85% on a year-on-year basis.
  • Net Profit: AURO LABORATORIES LTD. reported a net profit of ₹3.53 crore in FY26 vs ₹1.84 crore in FY25. It showed an increase of 91.85% on a yearly basis.

AURO LABORATORIES LTD. Quarterly Result Highlights

  • AURO LABORATORIES LTD. reported revenue of ₹9.82 crore in Sep 2025, compared with ₹3.19 crore in Jun 2025, representing an increase of 207.84% on a quarter-on-quarter (QoQ) basis.
  • AURO LABORATORIES LTD. reported an operating profit of ₹1.72 crore in Sep 2025, compared with ₹0.11 crore in Jun 2025, representing an increase of 1,663.64% on a quarter-on-quarter (QoQ) basis.
  • AURO LABORATORIES LTD. reported a profit of ₹0.72 crore in Sep 2025, compared with ₹0.11 crore in Jun 2025, reflecting an increase of 754.55% on a QoQ basis.
Know more
Promoters
52.41%
FII
0.00%
Other DII
0.00%
Retail and other
47.59%
Mutual funds
0.01%
Foreign institutions - FII
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Mkt Cap Cr
149.64
P/E
81.25
P/B
3.48
ROE
4.47%
D/E
1.21
ROCE
7.31%
Div. Yield
0.00%
EPS(TTM)
5.67
Turnover
0.33
EV/EBITDA
30.55
Net Margin
11.48%
Op. Margin
38.61%
ROA
1.55%
Quick Ratio
0.60
Curr. Ratio
0.95
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Auro Labs. has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Auro Labs. appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
Auro Labs. earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,66,155.0038.475.5813.74%0.6117.33%93.240.83%0.4810.90
Divis Laboratories2,26,843.0077.1513.4615.32%0.0019.56%629.490.35%0.5598.19
Torrent Pharmaceuticals1,86,000.0086.2722.1225.49%1.6913.85%222.760.69%0.4958.70
Zydus Lifesciences1,17,007.0026.154.4318.59%0.3117.35%237.300.08%0.3335.38
Cipla1,18,027.0035.173.4311.27%0.0014.95%423.360.89%0.4543.52
Lupin1,03,549.0018.624.6123.76%0.0424.88%659.050.79%0.57129.18
Mankind Pharma1,00,137.0048.436.1411.74%0.3413.13%397.020.04%0.4449.37
Dr. Reddy's Laboratories1,00,662.0031.622.6411.07%0.1812.54%377.960.67%0.4138.68
Laurus Labs99,474.2091.2318.7716.77%0.4016.14%97.200.11%0.6713.72
Aurobindo Pharma96,215.6026.062.559.25%0.1911.76%391.140.24%0.3841.58

AURO LABORATORIES LTD. Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025
Revenue20.06
Operating profit1.88
Net profit1.84

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹30.74₹19.12₹53.64₹52.89
Other Income₹2.01₹0.93₹1.50₹0.94
Total Revenue₹32.75₹20.05₹55.14₹53.84
Total Expenses₹27.80₹18.17₹44.79₹50.39
Profit Before Tax₹4.81₹1.88₹10.35₹3.45
Tax₹1.28₹0.04₹2.55₹1.00
Profit After Tax₹3.53₹1.84₹7.79₹2.44
EPS - Basic₹5.67₹2.95₹12.50₹3.92
EPS - Diluted₹5.67₹2.95₹12.50₹3.92

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹4.81₹1.88₹10.35₹3.45
Income before WC changes₹11.92₹3.78₹12.43₹5.58
Change in Assets-₹8.86₹8.32₹4.04-₹8.01
Change in Liabilities-₹0.95-₹6.36₹2.34₹5.72
Change in WC-₹9.81₹1.96₹6.38-₹2.30
Cash flow from Operations₹2.11₹5.02₹18.81₹3.28
Cash flow from Investing-₹14.78-₹23.70-₹38.67-₹5.08
Cash flow from Financing₹14.04₹17.69₹19.09-₹8.18
Total Cash Flow₹1.37-₹0.99-₹0.77-₹9.98
Cash (Start of the year)₹0.00₹0.99₹2.42₹12.40
Cash (End of the year)₹1.37₹0.00₹1.65₹2.42

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹90.32₹78.23₹54.88₹20.33
Current Assets₹30.77₹20.87₹30.85₹35.66
Total Assets₹121.08₹99.10₹85.73₹55.99
Current Liabilities₹28.55₹21.64₹23.93₹18.13
Net Current Asset₹2.21-₹0.77₹6.92₹17.53
Non-Current Liabilities₹46.18₹34.49₹19.84₹3.66
Equity Capital₹46.35₹42.97₹41.96₹34.20
Total Equity & Liabilities₹121.08₹99.10₹85.73₹55.99
* All values are in INR Crore
Qty
Bid
26
233.3
26
233.2
50
233.15
4
233.05
5
233
Ask
Qty
247.75
8
247.8
200
247.85
240
247.9
2
248
25
Bid Total: 111
Ask Total: 475
Buy orders: 19%
Sell orders: 81%
Bearish
2
Neutral
5
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
51.9
Neutral
ATR (14)
10.01
Neutral
STOCH(9,6)
68.86
Neutral
STOCH RSI (14)
98.39
Bearish
ADX(9)
28.54
Bearish
UO(9)
57.54
Neutral
ROC(12)
2.53
Bullish
WillR(14)
-31.14
Neutral
Period
Simple value
Exponential vaue
5D
238.5
238.98
10D
236.84
238.23
20D
238.41
239.49
50D
247.15
245.94
100D
256.01
251.92
Volume trend — traded volume by day
14 Aug0L
13 Aug0L
12 Aug0L
11 Aug0L
10 Aug0L
7 Aug0L
Average0L
Compare against other stocks
AURO LABORATORIES LTD. Share Price
AURO LABORATORIES LTD.
Pharmaceuticals
Add Stock
Add Another

AURO LABORATORIES LTD. Share Price FAQs